SCHRODER INVESTMENT MANAGEMENT GROUP
Position in BBOT — BridgeBio Oncology Therapeutics, Inc.
CIK 1086619
London, X0
Position in BBOT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,229,990
New position
Shares Held
249,161
first reported quarter
Ownership
0.311%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 67 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $603,082,920 across 77 Biotechnology names. BBOT ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
163,898 | $73,187,011 | |
| 2 | TECH |
BIO-TECHNE Corp
|
1,197,214 | $62,566,403 | |
| 3 | EXEL |
Exelixis, Inc.
|
525,533 | $22,540,109 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
66,662 | $22,056,454 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
648,827 | $21,722,727 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
39,852 | $20,861,326 | |
| 7 | INSM |
INSMED Inc
|
119,958 | $19,615,531 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
484,381 | $19,486,647 |
All Filings in BBOT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,229,990 | 249,161 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||